Perampanel: A selective AMPA antagonist for treating seizures

Research output: Contribution to journalReview article

Abstract

Perampanel is a selective, noncompetitive AMPA receptor antagonist that has recently been approved for treating localization-related epilepsy. This article reviews the pharmacology, clinical development, efficacy, and safety/tolerability of perampanel.

Original languageEnglish (US)
Pages (from-to)269-272
Number of pages4
JournalEpilepsy Currents
Volume13
Issue number6
DOIs
StatePublished - Nov 1 2013

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Perampanel: A selective AMPA antagonist for treating seizures'. Together they form a unique fingerprint.

  • Cite this